Device type · NIE
Catheter, Hemodialysis, Triple Lumen, Non-Implanted
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
NIE
Gastroenterology & Urology
Device class
Class II
FDA decisions since 2015
6
510(k), De Novo and PMA
Adverse event reports
40
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Catheter, Hemodialysis, Triple Lumen, Non-Implanted
- Product code
- NIE
- Device class
- Class II
- Review panel
- Gastroenterology & Urology
- Regulation
- 21 CFR 876.5540
- Specialty
- GI, Urology & Nephrology, Nephrology
- FDA record
- Classification database entry for NIE
Latest FDA decisions
Medical Components, Inc. (dba MedComp)
K232945 · Decided Nov 16, 2023 · 57 days after receipt
Device type: Catheter, Hemodialysis, Triple Lumen, Non-Implanted (NIE) · GI, Urology & Nephrology
Health Line International Corporation
K222170 · Decided Jan 13, 2023 · 176 days after receipt
Device type: Catheter, Hemodialysis, Triple Lumen, Non-Implanted (NIE) · GI, Urology & Nephrology
Medical Components, Inc. (dba MedComp)
K183219 · Decided Jun 14, 2019 · 206 days after receipt
Device type: Catheter, Hemodialysis, Triple Lumen, Non-Implanted (NIE) · GI, Urology & Nephrology
3 more FDA decisions with a free account
Reports received
40
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
35
88% of reports
Injury reports
5
13% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 10 | 0 | 1 | 0 |
| Jan 24 | 17 | 2 | 0 | 0 |
| Feb 24 | 9 | 2 | 0 | 0 |
| Mar 24 | 15 | 0 | 0 | 0 |
| Apr 24 | 3 | 0 | 0 | 0 |
| May 24 | 7 | 1 | 0 | 0 |
| Jun 24 | 5 | 0 | 1 | 0 |
| Jul 24 | 13 | 2 | 0 | 1 |
| Aug 24 | 8 | 2 | 1 | 0 |
| Sep 24 | 12 | 1 | 1 | 0 |
| Oct 24 | 9 | 0 | 0 | 0 |
| Nov 24 | 5 | 0 | 0 | 0 |
| Dec 24 | 6 | 1 | 1 | 0 |
| Jan 25 | 1 | 1 | 0 | 0 |
| Feb 25 | 7 | 1 | 0 | 0 |
| Mar 25 | 9 | 0 | 0 | 0 |
| Apr 25 | 8 | 1 | 1 | 0 |
| May 25 | 5 | 0 | 0 | 0 |
| Jun 25 | 6 | 2 | 0 | 0 |
| Jul 25 | 1 | 0 | 0 | 0 |
| Aug 25 | 6 | 3 | 0 | 0 |
| Sep 25 | 4 | 11 | 0 | 0 |
| Oct 25 | 3 | 1 | 0 | 0 |
| Nov 25 | 0 | 0 | 0 | 0 |
| Dec 25 | 2 | 1 | 0 | 0 |
| Jan 26 | 2 | 0 | 0 | 0 |
| Feb 26 | 11 | 0 | 0 | 0 |
| Mar 26 | 6 | 0 | 0 | 0 |
| Apr 26 | 3 | 0 | 0 | 0 |
| May 26 | 4 | 0 | 0 | 0 |
| Jun 26 | 2 | 0 | 0 | 0 |
| Jul 26 | 1 | 3 | 0 | 0 |
| Aug 26 | 2 | 1 | 0 | 0 |
| Sep 26 | 1 | 0 | 0 | 0 |
| Oct 26 | 1 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
2 more in this ranking with a free account
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Material Deformation9
- Material Frayed7
- Fluid/Blood Leak6
7 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions29
- Insufficient Information3
- Foreign Body In Patient2
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2660-2026 · Started May 21, 2026 · Posted by FDA Jul 2, 2026
Reason given: Due to lidocaine ampoules being manufactured under deficient manufacturing practices by manufacturer, lidocaine ampoules are currently being recalled by supplier.
Cause as FDA categorized it: Nonconforming Material/Component
Z-2661-2026 · Started May 21, 2026 · Posted by FDA Jul 2, 2026
Reason given: Due to lidocaine ampoules being manufactured under deficient manufacturing practices by manufacturer, lidocaine ampoules are currently being recalled by supplier.
Cause as FDA categorized it: Nonconforming Material/Component
Z-2374-2026 · Started Apr 21, 2026 · Posted by FDA Jun 13, 2026
Reason given: Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if sterility of a water-based injectable product is compromised this could lead to serious or...
Cause as FDA categorized it: Nonconforming Material/Component
35 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.